The World Health Organization and drugmaker Eli Lilly and Co. are warning patients to be wary of fake versions of weight-loss and diabetes medicines.

The Federal Trade Commission is challenging patents on 20 brand-name drugs, including the blockbuster weight-loss injection Ozempic.

For a Minnesota minor league baseball team known for a history of outlandish promotions, the idea of naming its longtime live pig mascot after the weight loss drug Ozempic made perfect sense.

The manager of the world’s largest sovereign wealth fund is pledging to push major oil and gas companies to speed up preparations for the “inescapable” transition away from fossil fuels.

Many people may be considering using Ozempic, Wegovy or another popular drug to shed some pounds, but one local woman says all that demand could be putting her heart health at risk.

The U.S. Food and Drug Administration says it has seized “thousands of units” of counterfeit Ozempic, the diabetes drug widely used for weight loss.

A new large study finds that the popular weight-loss drug Wegovy reduced the risk of serious heart problems by 20% in certain patients.

A doctor talks about the effects of the wildly popular new drugs and what you should know before and after starting one.

Supply problems and insurance complications have made it difficult for many patients to start and stay on new prescription medications used to treat obesity.

The U.S. Food and Drug Administration is warning consumers not to use versions of the popular weight-loss drug used in Ozempic and Wegovy and sold online because they might not contain the same ingredients as prescription products and may not be safe or effective.

Obesity is a major and growing problem around the world, but especially in the U.S. Researchers have long looked for medications that can help people lose weight, mostly with disappointing and, in some cases, dangerous results.

A diabetes drug being tested for weight loss is poised to further upend obesity care.